Jörg Hager

Dr Hager joined Integragen as Founder and Chief Scientific Officer in 2001.
Most recently, he was head of genotyping at the National Genotyping Center (France), joining in 1998.
In 1995, he moved to the Institut Pasteur in Lille (France) where he was involved in establishing the new department for the study of multi-factorial diseases of the CNRS.
There he headed the "Genetics of Obesity" research team that led to the identification of a major obesity susceptibility locus on chromosome 10 in 1997.
Dr Hager has over thirty (30) publications and five (5) patents, most of which are associated with the genetics of metabolic disorders, and Integragen's GenomeHIP technology.